FLUZALP QUADRIVALENT

Influenza Vaccine

FLUZALP Quadrivalent is a vaccine manufactured by Anzalp Pharmasolutions Pvt and helps protect against influenza illness (flu).. Ltd.. It is a vaccine meant for the age group of 4 years and above. The quadruple strain formula provides protection for up to 6 months*.  The product's dosage form is injection, suspension and is administered via intramuscular form.

Labeller Name: Anzalp Pharmasolutions Pvt. Ltd.

Dosage Form:  Suspension for Injection - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.

  • Influenza A Virus A/Nebraska/14/2019 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
  • Influenza A Virus A/Delaware/39/2019 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
  • Influenza B Virus B/Singapore/Inftt-16-0610/2016 Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
  • Influenza B Virus B/Darwin/7/2019 Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml

FLUZALP QUADRIVALENT (MULTI-DOSE VIAL) ACTIVE INGREDIENT(S)

ADMINISTRATION ROUTE

Intramuscular - Administration within a muscle.

  • Supplied as package of Single-dose vial, 0.5 mL (not made with natural rubber latex).
  • Multi-dose vial, 5 mL (not made with natural rubber latex). Supplied as package of 1. A maximum of ten doses can be withdrawn from the multi-dose vial.

HOW SUPPLIED

STORAGE AND HANDLING

Store all FLUZALP Quadrivalent presentations refrigerated at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Discard if vaccine has been frozen. Do not use after the expiration date shown on the label.